Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis.

Saved in:
Bibliographic Details
Title: Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis.
Authors: Gelissen LMY; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, Netherlands., van den Berg SPH; Department of Immunopathology, Sanquin Research Amsterdam, Amsterdam, Netherlands., Toorop AA; Department of Rehabilitation Medicine, MS Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands., Wijburg MT; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, Netherlands., Tallantyre EC; Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, United Kingdom.; Department of Neurology, University Hospital of Wales, Cardiff, United Kingdom., Derksen NIL; Department of Immunopathology, Sanquin Research Amsterdam, Amsterdam, Netherlands., Loeff FC; Biologics Laboratory, Sanquin Diagnostiek B.V., Amsterdam, Netherlands., Killestein J; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, Netherlands., Rispens T; Department of Immunopathology, Sanquin Research Amsterdam, Amsterdam, Netherlands.; Amsterdam UMC, location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, Amsterdam, Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Immunology, Amsterdam, Netherlands., van Kempen ZLE; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Corporate Authors: NEXT-MS study group
Source: Frontiers in immunology [Front Immunol] 2026 May 08; Vol. 17, pp. 1796273. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42183264
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gelissen+LMY%22">Gelissen LMY</searchLink>; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Berg+SPH%22">van den Berg SPH</searchLink>; Department of Immunopathology, Sanquin Research Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Toorop+AA%22">Toorop AA</searchLink>; Department of Rehabilitation Medicine, MS Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Wijburg+MT%22">Wijburg MT</searchLink>; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Tallantyre+EC%22">Tallantyre EC</searchLink>; Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, United Kingdom.; Department of Neurology, University Hospital of Wales, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Derksen+NIL%22">Derksen NIL</searchLink>; Department of Immunopathology, Sanquin Research Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Loeff+FC%22">Loeff FC</searchLink>; Biologics Laboratory, Sanquin Diagnostiek B.V., Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Killestein+J%22">Killestein J</searchLink>; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Rispens+T%22">Rispens T</searchLink>; Department of Immunopathology, Sanquin Research Amsterdam, Amsterdam, Netherlands.; Amsterdam UMC, location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, Amsterdam, Netherlands.; Amsterdam Institute for Immunology and Infectious Diseases, Immunology, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Kempen+ZLE%22">van Kempen ZLE</searchLink>; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam, Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22NEXT-MS+study+group%22">NEXT-MS study group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 May 08; Vol. 17, pp. 1796273. <i>Date of Electronic Publication: </i>2026 May 08 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42183264
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1796273
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1796273
    Titles:
      – TitleFull: Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gelissen LMY
      – PersonEntity:
          Name:
            NameFull: van den Berg SPH
      – PersonEntity:
          Name:
            NameFull: Toorop AA
      – PersonEntity:
          Name:
            NameFull: Wijburg MT
      – PersonEntity:
          Name:
            NameFull: Tallantyre EC
      – PersonEntity:
          Name:
            NameFull: Derksen NIL
      – PersonEntity:
          Name:
            NameFull: Loeff FC
      – PersonEntity:
          Name:
            NameFull: Killestein J
      – PersonEntity:
          Name:
            NameFull: Rispens T
      – PersonEntity:
          Name:
            NameFull: van Kempen ZLE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 05
              Text: 2026 May 08
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1